Rankings
▼
Calendar
CLDX Q2 2024 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CLDX
Celldex Therapeutics, Inc.
$2B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+832.1% YoY
Gross Profit
$2M
68.1% margin
Operating Income
-$46M
-1854.2% margin
Net Income
-$36M
-1434.8% margin
EPS (Diluted)
$-0.54
QoQ Revenue Growth
+1501.3%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$30M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$846M
Total Liabilities
$32M
Stockholders' Equity
$814M
Cash & Equivalents
$43M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$268,000
+832.1%
Gross Profit
$2M
-$26M
+106.5%
Operating Income
-$46M
-$33M
-39.5%
Net Income
-$36M
-$31M
-17.5%
Revenue Segments
Grant
$2M
100%
Service
$2,000
0%
← FY 2024
All Quarters
Q3 2024 →